1. Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients. Issue 2 (28th July 2020) Authors: Fan, Fuli; Yoo, Hyeon Joo; Stock, Sophia; Wang, Lei; Liu, Yibin; Schubert, Maria‐Luisa; Wang, Sanmei; Neuber, Brigitte; Hückelhoven‐Krauss, Angela; Gern, Ulrike; Schmitt, Anita; Müller‐Tidow, Carsten; Dreger, Peter; Schmitt, Michael; Sellner, Leopold Journal: International journal of cancer Issue: Volume 148:Issue 2(2021) Page Start: 419 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients. Issue 5 (28th February 2019) Authors: Stock, Sophia; Übelhart, Rudolf; Schubert, Maria‐Luisa; Fan, Fuli; He, Bailin; Hoffmann, Jean‐Marc; Wang, Lei; Wang, Sanmei; Gong, Wenjie; Neuber, Brigitte; Hückelhoven‐Krauss, Angela; Gern, Ulrike; Christ, Christiane; Hexel, Monika; Schmitt, Anita; Schmidt, Patrick; Krauss, Jürgen; Jäger, Dirk; ... Journal: International journal of cancer Issue: Volume 145:Issue 5(2019) Page Start: 1312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗